Published in J Neurol Neurosurg Psychiatry on May 01, 1985
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain (2010) 2.37
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med (2007) 2.08
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat Rev Neurosci (2013) 1.82
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry (2005) 1.75
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol (2005) 1.65
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (1989) 1.52
(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry (1991) 1.45
The cholinergic system and Parkinson disease. Behav Brain Res (2010) 1.38
Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry (1990) 1.19
Mild cognitive impairment in Parkinson's disease. Minerva Med (2011) 1.19
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry (2002) 1.16
A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1989) 1.15
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Parkinson's disease dementia: a neural networks perspective. Brain (2015) 1.10
Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol (2009) 1.09
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Rev Neurosci (2013) 1.03
Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1991) 0.98
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry (1987) 0.96
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry (1998) 0.96
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. J Neurol Neurosurg Psychiatry (1987) 0.93
Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evid Based Complement Alternat Med (2011) 0.92
Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. J Aging Res (2012) 0.91
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol (2015) 0.89
Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions. Acta Neuropathol (1987) 0.85
Early neurone loss in Alzheimer's disease: cortical or subcortical? Acta Neuropathol Commun (2015) 0.83
Transplantation of fetal cells and tissue: an overview. CMAJ (1994) 0.83
Laser Acupuncture at HT7 Acupoint Improves Cognitive Deficit, Neuronal Loss, Oxidative Stress, and Functions of Cholinergic and Dopaminergic Systems in Animal Model of Parkinson's Disease. Evid Based Complement Alternat Med (2014) 0.83
Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry (1998) 0.82
Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice. Dis Model Mech (2012) 0.82
Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research. Curr Neuropharmacol (2011) 0.82
Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors. PLoS One (2013) 0.81
New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease. Brain Res (2013) 0.81
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cereb Cortex (2015) 0.80
Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 0.80
The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview. J Neurol (2005) 0.79
The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults. Front Hum Neurosci (2016) 0.78
The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging. Mov Disord (2012) 0.78
Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease. Front Neurol (2015) 0.78
The nucleus basalis of Meynert in multi-infarct (vascular) dementia. Acta Neuropathol (1986) 0.78
Subcortical afferent projection systems in Huntington's chorea. Acta Neuropathol (1989) 0.78
Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PLoS One (2014) 0.77
Changes of brain gray matter structure in Parkinson's disease patients with dementia. Neural Regen Res (2013) 0.77
Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia. J Mov Disord (2010) 0.76
α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter. Sci Rep (2016) 0.76
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1987) 0.75
[Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type]. J Psychiatry Neurosci (1995) 0.75
New MRI Biomarkers Advance the Characterization of Parkinson Disease. Eur Neurol Rev (2013) 0.75
Visual hallucinations and the cholinergic system in dementia. J Neurol Neurosurg Psychiatry (1990) 0.75
Syndromic approach to Parkinson's disease: role of functional imaging. J Clin Neurol (2006) 0.75
Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies. F1000Res (2017) 0.75
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? NPJ Parkinsons Dis (2017) 0.75
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease. Curr Pharmacol Rep (2016) 0.75
Demonstration of Early Cognitive Impairment in Parkinson's Disease with Visual P300 Responses. Noro Psikiyatr Ars (2017) 0.75
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Observations on the brains of demented old people. J Neurol Sci (1970) 6.99
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J (1978) 3.59
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol (1983) 3.19
Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65
Human memory and the cholinergic system. A relationship to aging? Arch Neurol (1974) 2.24
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17
Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol (1983) 2.06
Dementia in Parkinson disease: a neuropathologic study. Neurology (1979) 2.02
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res (1982) 1.40
Neurotransmitter receptor alterations in Parkinson's disease. Life Sci (1977) 1.34
Clinical and electroencephalographic observations in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1958) 1.24
The E.E.G. in presenile dementia. J Neurol Neurosurg Psychiatry (1967) 1.21
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett (1982) 1.14
The electroencephalogram in Parkinson's syndrome. Electroencephalogr Clin Neurophysiol (1959) 1.11
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett (1983) 1.05
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat (1984) 0.92
Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet (1983) 0.91
Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol (1982) 0.89
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. J Neurol Sci (1984) 0.89
Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients. J Neurochem (1975) 0.87
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neurosci Lett (1984) 0.84
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Observations on the brains of demented old people. J Neurol Sci (1970) 6.99
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature (1982) 4.93
Asymmetric leaves1 mediates leaf patterning and stem cell function in Arabidopsis. Nature (2001) 4.17
Observations on the brains of non-demented old people. J Neurol Sci (1969) 4.06
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J (1978) 3.59
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
Staging and natural history of cerebrovascular pathology in dementia. Neurology (2012) 2.61
Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey. BMJ (2001) 2.59
Prevalence rates of dementia in an ageing population: are low rates due to the use of insensitive instruments? Age Ageing (1990) 2.45
The ontogeny of human gyrification. Cereb Cortex (1995) 2.32
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Initiation and execution of predictable and unpredictable movements in Parkinson's disease. Brain (1984) 2.27
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci (1990) 2.24
Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. Nature (1966) 2.23
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry (2004) 2.19
Malignant hypertension and cigarette smoking. Br Med J (1979) 2.13
Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ (1992) 2.12
The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci (1977) 2.07
Histochemical aspects of five limb muscles in old age. An autopsy study. J Neurol Sci (1971) 2.03
The effects of ageing and of cachexia upon skeletal muscle. A histopathological study. J Neurol Sci (1969) 2.00
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology (1999) 2.00
Necropsy evidence of central cholinergic deficits in senile dementia. Lancet (1977) 1.97
Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol Pharmacol (1999) 1.96
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Letter: Unusual cardiac and neurological reactions to narcotics. Lancet (1973) 1.90
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology (2000) 1.85
A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res (1981) 1.85
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci (1977) 1.83
Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol (1978) 1.82
Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci (1981) 1.78
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun (1995) 1.76
Iontophoretic release of acetylcholine, noradrenaline, 5-hydroxytryptamine and D-lysergic acid diethylamide from micropipettes. Br J Pharmacol (1970) 1.72
Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun (1995) 1.72
The Remler M2000 semi-automatic blood pressure recorder. Br Heart J (1979) 1.71
Radiation myelitis of the dorsolumbar spinal cord. Radiology (1969) 1.64
Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry (2001) 1.61
Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol (1972) 1.59
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
A neuronal basis for the alerting action of (+)-amphetamine. Br J Pharmacol (1972) 1.55
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
An outbreak of Norwalk virus gastroenteritis associated with eating raw oysters. Implications for maintaining safe oyster beds. JAMA (1995) 1.51
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Data on the distribution of fibre types in five human limb muscles. An autopsy study. J Neurol Sci (1971) 1.51
The contemporary natural history of mental disorder in old age. Br J Psychiatry (1982) 1.50
Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med (1992) 1.49
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48
The extensor digitorum brevis: histological and histochemical aspects. J Neurol Neurosurg Psychiatry (1972) 1.47
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry (2001) 1.44
Parkinsonism following electrical injury to the hand. Mov Disord (1998) 1.42
Central pontine myelinolysis. Two cases with associated electrolyte disturbance. Q J Med (1976) 1.40
Persistent involuntary movements after treatment with flupenthixol. Br Med J (Clin Res Ed) (1981) 1.39
Inositol monophosphatase inhibitors: a novel treatment for bipolar disorder? Biol Psychiatry (1995) 1.39
Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci (2001) 1.37
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci (1983) 1.34
Structure of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1992) 1.32